Stephanie Du Four

Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells

Sandra Van Lint, Dries Renmans, Katrijn Broos et al. · Cancer Immunology Research · 2016 · 128 citations · Full text

Life Sciences, Immunology, Oncology +17

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma

Sofie Wilgenhof, Stephanie Du Four, Frederik Vandenbroucke et al. · Journal of Immunotherapy · 2013 · 84 citations

Pharmacy, Oncology, Pharmacotherapy +17

Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor.

Sofie Wilgenhof, Veerle Morlion, Amélie Clémentine Seghers et al. · PubMed · 2012 · 82 citations

Medicine, Immunology, Oncology +17

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model

Stephanie Du Four, Sarah Maenhout, Kari De Pierre et al. · OncoImmunology · 2015 · 73 citations · Full text

Medicine, Immunology, Oncology +17

Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs.

Stephanie Du Four, Sarah Maenhout, Simone P. Niclou et al. · PubMed · 2016 · 72 citations · Full text

Medicine, Immunology, Oncology +17